Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resmetirom in Pediatric Subjects With MASH
NCT07763015Phase 2Recruiting
- Sponsor
- Madrigal Pharmaceuticals
- Start
- Aug 2026
- Primary completion
- Jul 2029
- Countries
- 1
01
Overview
A Phase 2 trial of resmetirom in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by Madrigal Pharmaceuticals. Started Aug 2026; status: recruiting.
02
Drugs
resmetirom
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on NCT07763015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07763015.